Publications by Hanne Flinstad Harbo

118 publications found

Publications 2018

  1. Sowa P, Harbo HF, White NS, Celius EG, Bartsch H, Berg-Hansen P, Moen SM, Bjørnerud A, Westlye LT, Andreassen OA, Dale AM, Beyer MK (2018)
    Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis
    Mult Scler, 1352458518765671 (in press)
    PubMed 29542336

Publications 2017

  1. de Rodez Benavent SA, Nygaard GO, Harbo HF, Tønnesen S, Sowa P, Landrø NI, Wendel-Haga M, Etholm L, Nilsen KB, Drolsum L, Kerty E, Celius EG, Laeng B (2017)
    Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients
    Brain Behav, 7 (7), e00717
    PubMed 28729927
  2. Hedström AK, Katsoulis M, Hössjer O, Bomfim IL, Oturai A, Sondergaard HB, Sellebjerg F, Ullum H, Thørner LW, Gustavsen MW, Harbo HF, Obradovic D, Gianfrancesco MA, Barcellos LF, Schaefer CA, Hillert J, Kockum I, Olsson T, Alfredsson L (2017)
    The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement
    Eur J Epidemiol, 32 (10), 909-919
    PubMed 28597127
  3. Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, Jonasson JG, Olafsson JH, Orvar KB, Benediktsson R, Bjarnason R, Kristjansdottir S, Gislason T, Valdimarsson T, Mikaelsdottir E, Sigurdsson S et al. (2017)
    Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
    NPJ Genom Med, 2, 24
    PubMed 29263835
  4. Sowa P, Nygaard GO, Bjørnerud A, Celius EG, Harbo HF, Beyer MK (2017)
    Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis
    Neuroradiology, 59 (7), 655-664
    PubMed 28585082

Publications 2016

  1. Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A (2016)
    The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
    Genes Immun, 17 (2), 118-27
    PubMed 26765264
  2. Bos SD, Berge T, Celius EG, Harbo HF (2016)
    From genetic associations to functional studies in multiple sclerosis
    Eur J Neurol, 23 (5), 847-53
    PubMed 26948534
  3. George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL et al. (2016)
    Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
    Neurol Genet, 2 (4), e87
    PubMed 27540591
  4. Gustavsen MW, Celius EG, Winsvold BS, Moen SM, Nygaard GO, Berg-Hansen P, Lie BA, Zwart JA, Harbo HF (2016)
    Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
    Mult Scler J Exp Transl Clin, 2, 2055217316682976
    PubMed 28607748
  5. Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T (2016)
    Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood
    BMC Genet, 17, 59
    PubMed 27080863
  6. Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA et al. (2016)
    Power estimation for non-standardized multisite studies
    Neuroimage, 134, 281-294
    PubMed 27039700
  7. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [No title available]
    Tidsskr Nor Laegeforen, 136 (20), 1702
    PubMed 27830899
  8. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [No title available]
    Tidsskr Nor Laegeforen, 136 (19), 1608
    PubMed 27790879
  9. Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
    [MRI in multiple sclerosis]
    Tidsskr Nor Laegeforen, 136 (16), 1373-6
    PubMed 27637059
  10. Wang Y, Bos SD, Harbo HF, Thompson WK, Schork AJ, Bettella F, Witoelar A, Lie BA, Li W, McEvoy LK, Djurovic S, Desikan RS, Dale AM, Andreassen OA (2016)
    Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors
    Mult Scler, 22 (14), 1783-1793
    PubMed 26920376

Publications 2015

  1. Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2015)
    Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'
    Acta Neurol Scand, 132 (5), 364-7
    PubMed 26423981
  2. Bos SD, Page CM, Andreassen BK, Elboudwarej E, Gustavsen MW, Briggs F, Quach H, Leikfoss IS, Bjølgerud A, Berge T, Harbo HF, Barcellos LF (2015)
    Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis
    PLoS One, 10 (3), e0117403
    PubMed 25734800
  3. Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B et al. (2015)
    Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
    Brain, 138 (Pt 3), 632-43
    PubMed 25616667
  4. Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T (2015)
    Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells
    PLoS One, 10 (7), e0132957
    PubMed 26203907
  5. Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A et al. (2015)
    Class II HLA interactions modulate genetic risk for multiple sclerosis
    Nat Genet, 47 (10), 1107-1113
    PubMed 26343388
  6. Nygaard GO, Celius EG, de Rodez Benavent SA, Sowa P, Gustavsen MW, Fjell AM, Landrø NI, Walhovd KB, Harbo HF (2015)
    A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity
    PLoS One, 10 (8), e0135974
    PubMed 26280173
  7. Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG (2015)
    Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis
    Mult Scler Relat Disord, 4 (6), 585-9
    PubMed 26590666
  8. Page CM, Baranzini SE, Mevik BH, Bos SD, Harbo HF, Andreassen BK (2015)
    Assessing the Power of Exome Chips
    PLoS One, 10 (10), e0139642
    PubMed 26437075
  9. Seldin MF, Alkhairy OK, Lee AT, Lamb JA, Sussman J, Pirskanen-Matell R, Piehl F, Verschuuren JJ, Kostera-Pruszczyk A, Szczudlik P, Mckee D, Maniaol AH, Harbo HF, Lie BA, Melms A, Garchon HJ, Willcox N, Gregersen PK, Hammarstrom L (2015)
    Genome-wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A, and Identification of ZBTB10 and Three Distinct HLA Associations
    Mol Med, 21, 769-781
    PubMed 26562150
  10. Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK (2015)
    Reduced perfusion in white matter lesions in multiple sclerosis
    Eur J Radiol, 84 (12), 2605-12
    PubMed 26391230

Publications 2014

  1. Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P, Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups, International Multiple Sclerosis Genetics Consortium (IMSGC), McEvoy LK, Desikan RS, Lie BA, Djurovic S, Dale AM (2014)
    Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci
    Mol Psychiatry, 20 (2), 207-14
    PubMed 24468824
  2. Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C et al. (2014)
    VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
    Ann Clin Transl Neurol, 1 (5), 329-39
    PubMed 25356403
  3. Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2014)
    High prevalence and no latitude gradient of multiple sclerosis in Norway
    Mult Scler, 20 (13), 1780-2
    PubMed 24603884
  4. Berg-Hansen P, Moen SM, Sandvik L, Harbo HF, Bakken IJ, Stoltenberg C, Celius EG (2014)
    Prevalence of multiple sclerosis among immigrants in Norway
    Mult Scler, 21 (6), 695-702
    PubMed 25344371
  5. Eriksen AB, Berge T, Gustavsen MW, Leikfoss IS, Bos SD, Spurkland A, Harbo HF, Blomhoff HK (2014)
    Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing-remitting multiple sclerosis
    J Neuroimmunol, 278, 11-8
    PubMed 25595247
  6. Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF (2014)
    No association between multiple sclerosis and periodontitis after adjusting for smoking habits
    Eur J Neurol, 22 (3), 588-90
    PubMed 25041906
  7. Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF (2014)
    Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
    BMC Neurol, 14, 196
    PubMed 25274070
  8. Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
    Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
    J Neuroimmunol, 274 (1-2), 174-9
    PubMed 25037176
  9. Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF (2014)
    Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis
    Mult Scler, 21 (4), 402-14
    PubMed 25139946
  10. Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O (2014)
    Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
    Eur J Neurol, 22 (2), 328-333
    PubMed 25311247
  11. Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J (2014)
    Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
    Eur J Hum Genet, 23 (5), 688-92
    PubMed 25159868

Publications 2013

  1. Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A (2013)
    No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
    Ann Neurol, 73 (3), 430-2
    PubMed 23444327
  2. Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG (2013)
    Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway
    Eur J Neurol, 20 (12), 1546-52
    PubMed 23834430
  3. Berge T, Leikfoss IS, Harbo HF (2013)
    From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
    Int J Mol Sci, 14 (3), 4476-97
    PubMed 23439554
  4. Harbo HF, Gold R, Tintoré M (2013)
    Sex and gender issues in multiple sclerosis
    Ther Adv Neurol Disord, 6 (4), 237-48
    PubMed 23858327
  5. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA (2013)
    Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
    Mult Scler, 20 (6), 660-8
    PubMed 24099750
  6. Høglund RA, Holmøy T, Harbo HF, Maghazachi AA (2013)
    A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)
    PLoS One, 8 (4), e62237
    PubMed 23614042
  7. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M et al. (2013)
    Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
    Nat Genet, 45 (11), 1353-60
    PubMed 24076602
  8. Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, Hauser SL, Oksenberg JR (2013)
    Genetic risk variants in African Americans with multiple sclerosis
    Neurology, 81 (3), 219-27
    PubMed 23771490
  9. Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR, PROGEMUS Group, PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S (2013)
    Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
    PLoS One, 8 (6), e64408
    PubMed 23785401
  10. Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
    Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
    PLoS One, 8 (3), e58352
    PubMed 23472185

Publications 2012

  1. Brambilla P, Esposito F, Lindstrom E, Sorosina M, Giacalone G, Clarelli F, Rodegher M, Colombo B, Moiola L, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, Celius EG, Galimberti D, Sørensen PS, Martinelli V, Oturai AB, Harbo HF, Hillert J, Comi G, Martinelli-Boneschi F (2012)
    Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans
    Neurosci Lett, 530 (2), 155-60
    PubMed 23069673
  2. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE (2012)
    The genetics of multiple sclerosis: an up-to-date review
    Immunol Rev, 248 (1), 87-103
    PubMed 22725956
  3. Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A et al. (2012)
    Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08
    Ann Neurol, 72 (6), 927-35
    PubMed 23055271
  4. Harbo HF, Mero IL (2012)
    From genes to characteristics of multiple sclerosis
    Acta Neurol Scand Suppl (195), 76-83
    PubMed 23278661
  5. Leikfoss IS, Mero IL, Dahle MK, Lie BA, Harbo HF, Spurkland A, Berge T (2012)
    Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus
    Genes Immun, 14 (1), 62-6
    PubMed 23151489
  6. Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J (2012)
    Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis
    PLoS One, 7 (5), e36779
    PubMed 22586495
  7. Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CM (2012)
    Smoking and socio-economic status may affect myasthenia gravis
    Eur J Neurol, 20 (3), 453-60
    PubMed 22934661
  8. Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012)
    Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population
    PLoS One, 7 (5), e36603
    PubMed 22590574
  9. Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, Stankovich J, Rodegher M, Capra R, Ghezzi A, Coniglio G, Colombo B, Sorosina M, Martinelli V, Booth D, Oturai AB, Stewart G, Harbo HF, Kilpatrick TJ, Hillert J, Rubio JP, Abderrahim H, Wojcik J, Comi G (2012)
    A genome-wide association study in progressive multiple sclerosis
    Mult Scler, 18 (10), 1384-94
    PubMed 22457343
  10. Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF (2012)
    Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course
    J Neuroimmunol, 244 (1-2), 107-10
    PubMed 22341604

Publications 2011

  1. Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J, EFNS (2011)
    EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders
    Eur J Neurol, 18 (2), 207-17
    PubMed 20500522
  2. Hansen B, Oturai AB, Harbo HF, Celius EG, Nissen KK, Laska MJ, Søndergaard HB, Petersen T, Nexø BA (2011)
    Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes
    PLoS One, 6 (10), e26438
    PubMed 22039488
  3. Harbo HF, Lorentzen AR, Lie BA, Celius EG, Spurkland A (2011)
    [New gene map for multiple sclerosis]
    Tidsskr Nor Laegeforen, 131 (21), 2126-30
    PubMed 22048209
  4. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B et al. (2011)
    Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
    Nature, 476 (7359), 214-9
    PubMed 21833088
  5. Lundström W, Greiner E, Lundmark F, Westerlind H, Smestad C, Lorentzen AR, Kockum I, Link J, Brynedal B, Celius EG, Harbo HF, Masterman T, Hillert J (2011)
    No influence on disease progression of non-HLA susceptibility genes in MS
    J Neuroimmunol, 237 (1-2), 98-100
    PubMed 21742385
  6. Pandya AD, Al-Jaderi Z, Høglund RA, Holmøy T, Harbo HF, Norgauer J, Maghazachi AA (2011)
    Identification of human NK17/NK1 cells
    PLoS One, 6 (10), e26780
    PubMed 22039549
  7. Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB (2011)
    Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655
    Eur J Hum Genet, 19 (10), 1100-3
    PubMed 21610746

Publications 2010

  1. Beyeen AD, Adzemovic MZ, Ockinger J, Stridh P, Becanovic K, Laaksonen H, Lassmann H, Harris RA, Hillert J, Alfredsson L, Celius EG, Harbo HF, Kockum I, Jagodic M, Olsson T (2010)
    IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
    J Immunol, 185 (11), 6883-90
    PubMed 21041731
  2. Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T, EFNS (2010)
    EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias
    Eur J Neurol, 17 (5), 641-8
    PubMed 20298421
  3. Holmøy T, Harbo HF, Celius EG (2010)
    [Treatment of multiple sclerosis]
    Tidsskr Nor Laegeforen, 130 (9), 923; author reply 923
    PubMed 20453948
  4. International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, Saarela J, Leppä V, Peltonen L, Pirttila T, Cournu-Rebeix I, Fontaine B, Bergamaschi L, D'Alfonso S, Leone M, Lorentzen AR, Harbo HF, Celius EG, Spurkland A, Link J, Kockum I et al. (2010)
    Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis
    Nat Genet, 42 (6), 469-70; author reply 470-1
    PubMed 20502484
  5. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA et al. (2010)
    Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene
    Am J Hum Genet, 86 (2), 285-91
    PubMed 20159113
  6. Link J, Lorentzen AR, Kockum I, Duvefelt K, Lie BA, Celius EG, Harbo HF, Hillert J, Brynedal B (2010)
    Two HLA class I genes independently associated with multiple sclerosis
    J Neuroimmunol, 226 (1-2), 172-6
    PubMed 20678810
  7. Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF (2010)
    Association to the Glypican-5 gene in multiple sclerosis
    J Neuroimmunol, 226 (1-2), 194-7
    PubMed 20692050
  8. Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF (2010)
    Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus
    Genes Immun, 12 (3), 191-8
    PubMed 21179112
  9. Nohra R, Beyeen AD, Guo JP, Khademi M, Sundqvist E, Hedreul MT, Sellebjerg F, Smestad C, Oturai AB, Harbo HF, Wallström E, Hillert J, Alfredsson L, Kockum I, Jagodic M, Lorentzen J, Olsson T (2010)
    RGMA and IL21R show association with experimental inflammation and multiple sclerosis
    Genes Immun, 11 (4), 279-93
    PubMed 20072140

Publications 2009

  1. Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, Ivinson AJ, McCauley JL, Pericak-Vance M et al. (2009)
    Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
    Eur J Hum Genet, 17 (10), 1309-13
    PubMed 19293837
  2. Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Gasser T, European Federation of Neurological Sciences (2009)
    EFNS guidelines on the molecular diagnosis of mitochondrial disorders
    Eur J Neurol, 16 (12), 1255-64
    PubMed 19950421
  3. Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Harbo HF, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias
    Eur J Neurol, 17 (2), 179-88
    PubMed 20050888
  4. Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias
    Eur J Neurol, 16 (7), 777-85
    PubMed 19469830
  5. Harbo HF, Riccio ME, Lorentzen AR, Utsi E, Myhr KM, Mellgren SI, Flåm ST, Thorsby E, Sanchez-Mazas A, Lie BA (2009)
    Norwegian Sami differs significantly from other Norwegians according to their HLA profile
    Tissue Antigens, 75 (3), 207-17
    PubMed 20047643
  6. Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
    Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
    Curr Mol Med, 9 (5), 591-611
    PubMed 19601809
  7. Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M, Casemayou A, Lamouroux L, Duthoit C, Papapietro O, Sjöholm L, Bernard I, Lagrange D, Dahlman I, Lundmark F, Oturai AB, Soendergaard HB, Kemppinen A, Saarela J, Tienari PJ, Harbo HF, Spurkland A, Ramagopalan SV, Sadovnick DA, Ebers GC et al. (2009)
    A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis
    Sci Transl Med, 1 (10), 10ra21
    PubMed 20368159
  8. Kallio SP, Jakkula E, Purcell S, Suvela M, Koivisto K, Tienari PJ, Elovaara I, Pirttilä T, Reunanen M, Bronnikov D, Viander M, Meri S, Hillert J, Lundmark F, Harbo HF, Lorentzen AR, De Jager PL, Daly MJ, Hafler DA, Palotie A, Peltonen L, Saarela J (2009)
    Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS
    Hum Mol Genet, 18 (9), 1670-83
    PubMed 19221116
  9. Kemppinen A, Suvela M, Tienari PJ, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Rautakorpi I, Hillert J, Lundmark F, Oturai A, Ryder L, Harbo HF, Celius EG, Palotie A, Daly M, Peltonen L, Saarela J (2009)
    MYO9B polymorphisms in multiple sclerosis
    Eur J Hum Genet, 17 (6), 840-3
    PubMed 19142207
  10. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF (2009)
    Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis
    Ann Neurol, 65 (6), 658-66
    PubMed 19630074
  11. Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF (2009)
    A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis
    Eur J Hum Genet, 18 (4), 502-4
    PubMed 19888296
  12. Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC (2009)
    HLA-DRB1 and month of birth in multiple sclerosis
    Neurology, 73 (24), 2107-11
    PubMed 20018638

Publications 2008

  1. Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF (2008)
    The SH2D2A gene and susceptibility to multiple sclerosis
    J Neuroimmunol, 197 (2), 152-8
    PubMed 18554728
  2. Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C (2008)
    Environmental risk factors in multiple sclerosis
    Acta Neurol Scand Suppl, 188, 34-40
    PubMed 18439219

Publications 2007

  1. Datta P, Harbo HF, Ryder LP, Akesson E, Benedikz J, Celius EG, Andersen O, Myhr KM, Sandberg-Wollheim M, Hillert J, Svejgaard A, Sorensen PS, Spurkland A, Oturai A (2007)
    A follow-up study of Nordic multiple sclerosis candidate gene regions
    Mult Scler, 13 (5), 584-9
    PubMed 17548436
  2. Harbo HF, Mørk S, Vedeler C, Myhr KM (2007)
    [Multiple sclerosis biobank established]
    Tidsskr Nor Laegeforen, 127 (17), 2276
    PubMed 17828328
  3. Harbo HF, Spurkland A (2007)
    Genetics in multiple sclerosis: past and future perspectives
    Acta Neurol Scand Suppl, 187, 34-8
    PubMed 17419826
  4. Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E (2007)
    Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami
    Tissue Antigens, 69 (4), 299-304
    PubMed 17389012
  5. Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, Hillert J, Myhr KM, Marrosu MG, Oksenberg JR, Rajda C, Sawcer SJ, Sørensen PS et al. (2007)
    Familial effects on the clinical course of multiple sclerosis
    Neurology, 68 (5), 376-83
    PubMed 17261686
  6. Knudsen GP, Harbo HF, Smestad C, Celius EG, Akesson E, Oturai A, Ryder LP, Spurkland A, Ørstavik KH (2007)
    X chromosome inactivation in females with multiple sclerosis
    Eur J Neurol, 14 (12), 1392-6
    PubMed 17970735
  7. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007)
    Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
    Nat Genet, 39 (9), 1108-13
    PubMed 17660816
  8. Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF (2007)
    The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
    Eur J Neurol, 14 (8), 835-40
    PubMed 17662002
  9. Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2007)
    Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
    J Neurol, 255 (1), 49-55
    PubMed 18080855

Publications 2006

  1. Games Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J, Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K et al. (2006)
    Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
    J Neuroimmunol, 179 (1-2), 108-16
    PubMed 16934875
  2. Harbo HF, Ekstrøm PO, Lorentzen AR, Sundvold-Gjerstad V, Celius EG, Sawcer S, Spurkland A (2006)
    Coding region polymorphisms in T cell signal transduction genes. Prevalence and association to development of multiple sclerosis
    J Neuroimmunol, 177 (1-2), 40-5
    PubMed 16764945
  3. Lundmark F, Harbo HF, Celius EG, Saarela J, Datta P, Oturai A, Lindgren CM, Masterman T, Salter H, Hillert J (2006)
    Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations
    J Neuroimmunol, 180 (1-2), 193-8
    PubMed 17020785
  4. Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
    No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
    Scand J Gastroenterol, 41 (5), 586-91
    PubMed 16638702

Publications 2005

  1. Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
    Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
    J Neuroimmunol, 166 (1-2), 197-201
    PubMed 16005527
  2. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory SG, Schmidt S, Pericak-Vance MA, Akesson E, Hillert J, Datta P, Oturai A, Ryder LP, Harbo HF, Spurkland A, Myhr KM et al. (2005)
    A high-density screen for linkage in multiple sclerosis
    Am J Hum Genet, 77 (3), 454-67
    PubMed 16080120
  3. Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S, Førre Ø, Thorsby E, Lie BA (2005)
    Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci
    Rheumatology (Oxford), 44 (11), 1368-73
    PubMed 16174649
  4. Torkildsen O, Utsi E, Harbo HF, Mellgren SI, Vedeler CA, Myhr KM (2005)
    Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population
    Scand J Immunol, 62 (1), 71-4
    PubMed 16091126
  5. Torkildsen O, Utsi E, Mellgren SI, Harbo HF, Vedeler CA, Myhr KM (2005)
    Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations
    Immunology, 115 (3), 416-21
    PubMed 15946259

Publications 2004

  1. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004)
    Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
    Tissue Antigens, 63 (3), 237-47
    PubMed 14989713
  2. Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS (2004)
    Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs
    Mult Scler, 10 (1), 5-8
    PubMed 14760946

Publications 2003

  1. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A, Sawcer S (2003)
    Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis
    J Neuroimmunol, 143 (1-2), 31-8
    PubMed 14575911
  2. Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003)
    Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
    J Neuroimmunol, 143 (1-2), 101-6
    PubMed 14575924
  3. Myhr KM, Harbo HF (2003)
    [Multiple sclerosis--a disease with complex genetics]
    Tidsskr Nor Laegeforen, 123 (19), 2723-6
    PubMed 14600746

Publications 2002

  1. Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF, Laaksonen M, Myhr KM, Nyland HI, Ryder LP, Sandberg-Wollheim M, Sorensen PS, Spurkland A, Svejgaard A, Holmans P, Compston A, Hillert J, Sawcer S (2002)
    A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis
    Genes Immun, 3 (5), 279-85
    PubMed 12140746

Publications 2001

  1. Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A (2001)
    The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis
    Genes Immun, 2 (5), 263-8
    PubMed 11528519
  2. Dai Y, Masterman T, Huang WX, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Oturai A, Ryder LP, Soelberg-Sørensen P, Svejgaard A, Hillert J (2001)
    Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients
    Mult Scler, 7 (3), 157-63
    PubMed 11475438
  3. Isojärvi JI, Taubøll E, Pakarinen AJ, van Parys J, Rättyä J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS (2001)
    Altered ovarian function and cardiovascular risk factors in valproate-treated women
    Am J Med, 111 (4), 290-6
    PubMed 11566460

Publications 2000

  1. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000)
    Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
    J Neurol Sci, 178 (2), 132-5
    PubMed 11018705
  2. Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A (2000)
    Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q
    Genes Immun, 1 (7), 456-9
    PubMed 11196677

Publications 1999

  1. Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
    CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
    Tissue Antigens, 53 (1), 106-10
    PubMed 10082437
  2. Taubøll E, Isojärvi JI, Harbo HF, Pakarinen AJ, Gjerstad L (1999)
    Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats
    Seizure, 8 (8), 490-3
    PubMed 10627413

Publications 1996

  1. Harbo HF (1996)
    [Brain abscess. A difficult diagnosis?]
    Tidsskr Nor Laegeforen, 116 (7), 866-8
    PubMed 8644101
 
Apr 15, 2011 Page visits: 3084